{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:59:25Z","timestamp":1761872365852,"version":"build-2065373602"},"reference-count":60,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clml.2023.06.010","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T16:07:06Z","timestamp":1687795626000},"page":"e348-e359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment Individualization in Diffuse Large B-Cell Lymphoma: Is Frailty Enough for Old Adults? An Original Article"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2555-9287","authenticated-orcid":false,"given":"Agurne","family":"Garc\u00eda-Bazt\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7765-370X","authenticated-orcid":false,"given":"Julio","family":"Oteiza-Olaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy Jeanette","family":"Gonzales-Montejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Fernanda","family":"Ram\u00f3n-Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2860-3359","authenticated-orcid":false,"given":"Ibai","family":"Tamayo-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9576-9960","authenticated-orcid":false,"given":"Nicol\u00e1s","family":"Mart\u00ednez-Velilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari Cruz","family":"Viguria-Alegria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.clml.2023.06.010_bib0001","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1200\/JCO.21.00242","article-title":"Advances in management for older adults with hematologic malignancies","volume":"39","author":"Rosko","year":"2021","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.clml.2023.06.010_bib0002","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers","year":"2014","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clml.2023.06.010_bib0003","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11899-018-0454-x","article-title":"Frailty in hematologic malignancy","volume":"13","author":"Koll","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.clml.2023.06.010_bib0004","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11912-021-01097-9","article-title":"Determination of biological age: geriatric assessment vs biological biomarkers","volume":"23","author":"Diebel","year":"2021","journal-title":"Curr Oncol Rep."},{"issue":"6","key":"10.1016\/j.clml.2023.06.010_bib0005","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/S1470-2045(18)30348-6","article-title":"Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer","volume":"19","author":"Soto-Perez-de-Celis","year":"2018","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.clml.2023.06.010_bib0006","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: an expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.clml.2023.06.010_bib0007","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cger.2010.02.002","article-title":"The assessment of frailty in older adults","volume":"26","author":"Abellan van Kan","year":"2010","journal-title":"Clin Geriatr Med"},{"issue":"3","key":"10.1016\/j.clml.2023.06.010_bib0008","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol - Ser A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.clml.2023.06.010_bib0009","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: Revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"4","key":"10.1016\/j.clml.2023.06.010_bib0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/17843286.2016.1162381","article-title":"Hand grip strength as a screening tool for frailty in older patients with haematological malignancies","volume":"71","author":"Velghe","year":"2016","journal-title":"Acta Clin Belgica Int J Clin Lab Med"},{"issue":"3","key":"10.1016\/j.clml.2023.06.010_bib0011","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jgo.2021.12.002","article-title":"The role of grip strength and short physical performance battery test in predicting chemotherapy-related outcomes in older adults with cancer","volume":"13","author":"Almugbel","year":"2022","journal-title":"J Geriatr Oncol"},{"issue":"4","key":"10.1016\/j.clml.2023.06.010_bib0012","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood.2019000758","article-title":"Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies","volume":"134","author":"Liu","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2023.06.010_bib0013","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1532-5415.2009.02620.x","article-title":"Physical performance and subsequent disability and survival in older adults with malignancy: results from the health, aging and Body Composition Study","volume":"58","author":"Klepin","year":"2010","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.clml.2023.06.010_bib0014","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/0269216319825972","article-title":"Frailty identified by geriatric assessment is associated with poor functioning, high symptom burden and increased risk of physical decline in older cancer patients: prospective observational study","volume":"33","author":"Kirkhus","year":"2019","journal-title":"Palliat Med"},{"issue":"11","key":"10.1016\/j.clml.2023.06.010_bib0015","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1016\/S2352-3026(21)00241-6","article-title":"A comprehensive approach to therapy of haematological malignancies in older patients","volume":"8","author":"Cordoba","year":"2021","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.clml.2023.06.010_bib0016","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/S1470-2045(20)30473-3","article-title":"Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative","volume":"22","author":"Extermann","year":"2021","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.clml.2023.06.010_bib0017","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3324\/haematol.2019.245803","article-title":"Geriatric assessment in older patients with hematologic malignancy: a systematic review","volume":"105","author":"Scheepers","year":"2020","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.clml.2023.06.010_bib0018","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1200\/JCO.20.02465","article-title":"Simplified geriatric assessment in older patients with diffuse large B-cell lymphoma: the Prospective Elderly Project of the Fondazione Italiana Linfomi","volume":"39","author":"Merli","year":"2021","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.clml.2023.06.010_bib0019","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S2666-7568(21)00182-3","article-title":"Implementation of geriatric haematology programmes for the treatment of older people with haematological malignancies in low-resource settings","volume":"2","author":"Soto-Perez-de-Celis","year":"2021","journal-title":"Lancet Heal Longev"},{"issue":"11","key":"10.1016\/j.clml.2023.06.010_bib0020","doi-asserted-by":"crossref","first-page":"e736","DOI":"10.1016\/S2666-7568(21)00184-7","article-title":"Frailty assessment in the care of older people with haematological malignancies","volume":"2","author":"Goede","year":"2021","journal-title":"Lancet Heal Longev"},{"issue":"12","key":"10.1016\/j.clml.2023.06.010_bib0021","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1080\/0284186X.2016.1219047","article-title":"Physical performance measures for predicting outcome in cancer patients: a systematic review","volume":"55","author":"Verweij","year":"2016","journal-title":"Acta Oncol (Madr)"},{"issue":"3","key":"10.1016\/j.clml.2023.06.010_bib0022","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1532-5415.2008.02136.x","article-title":"Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the Three-City Study","volume":"57","author":"\u00c1vila-Funes","year":"2009","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.clml.2023.06.010_bib0023","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jgo.2015.12.002","article-title":"Comorbidity in older adults with cancer","volume":"7","author":"Williams","year":"2016","journal-title":"J Geriatr Oncol"},{"issue":"7","key":"10.1016\/j.clml.2023.06.010_bib0024","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.clml.2023.06.010_bib0025","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.clml.2023.06.010_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6215-15-34","article-title":"An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes - the MID-Frail study: study protocol for a randomised controlled trial","volume":"15","author":"Rodr\u00edguez-Ma\u00f1as","year":"2014","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.clml.2023.06.010_bib0027","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/jcsm.12925","article-title":"Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial","volume":"13","author":"Casas-Herrero","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.clml.2023.06.010_bib0028","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"10","key":"10.1016\/j.clml.2023.06.010_bib0029","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1007\/s12094-018-1856-x","article-title":"General recommendations paper on the management of older patients with cancer: the SEOM geriatric oncology task force's position statement","volume":"20","author":"Giron\u00e9s Sarri\u00f3","year":"2018","journal-title":"Clin Transl Oncol"},{"issue":"5","key":"10.1016\/j.clml.2023.06.010_bib0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"issue":"3","key":"10.1016\/j.clml.2023.06.010_bib0031","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1634\/theoncologist.5-3-224","article-title":"Management of cancer in the older person: a practical approach","volume":"5","author":"Balducci","year":"2000","journal-title":"Oncologist"},{"issue":"19","key":"10.1016\/j.clml.2023.06.010_bib0032","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1002\/cncr.24490","article-title":"A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy","volume":"115","author":"Tucci","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2023.06.010_bib0033","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11912-020-00976-x","article-title":"Diffuse large B-cell lymphoma in the elderly: current approaches","volume":"22","author":"Allen","year":"2020","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"10.1016\/j.clml.2023.06.010_bib0034","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1470-2045(11)70069-9","article-title":"Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial","volume":"12","author":"Peyrade","year":"2011","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.clml.2023.06.010_bib0035","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S2352-3026(20)30031-4","article-title":"Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis","volume":"7","author":"Linschoten","year":"2020","journal-title":"Lancet Haematol"},{"issue":"27","key":"10.1016\/j.clml.2023.06.010_bib0036","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-hodgkin lymphoma: the lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.clml.2023.06.010_bib0037","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jgo.2022.02.005","article-title":"Geriatric assessment in older adults with non-Hodgkin lymphoma: a Young International Society of Geriatric Oncology (YSIOG) review paper","volume":"13","author":"Akhtar","year":"2022","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"10.1016\/j.clml.2023.06.010_bib0038","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/bjh.16049","article-title":"Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations","volume":"187","author":"Ong","year":"2019","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.clml.2023.06.010_bib0039","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"C Can Med Assoc J"},{"issue":"6","key":"10.1016\/j.clml.2023.06.010_bib0040","doi-asserted-by":"crossref","first-page":"635","DOI":"10.6004\/jnccn.2022.7014","article-title":"Frailty in patients with newly diagnosed diffuse large B-cell lymphoma receiving curative-intent therapy: a Population-Based Study","volume":"20","author":"Vijenthira","year":"2022","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"issue":"1","key":"10.1016\/j.clml.2023.06.010_bib0041","first-page":"59","article-title":"Evidence-based minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignancies","volume":"2019","author":"Lin","year":"2019","journal-title":"Hematol (United States)"},{"issue":"21","key":"10.1016\/j.clml.2023.06.010_bib0042","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1182\/blood-2012-12-471680","article-title":"Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia","volume":"121","author":"Klepin","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.clml.2023.06.010_bib0043","doi-asserted-by":"crossref","first-page":"e898","DOI":"10.1016\/j.clml.2022.06.003","article-title":"Diffuse large B-cell lymphoma in the elderly: real-world outcomes from a developing country","volume":"22","author":"Jobanputra","year":"2022","journal-title":"Clin Lymphoma, Myeloma Leuk"},{"issue":"4","key":"10.1016\/j.clml.2023.06.010_bib0044","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1634\/theoncologist.2014-0247","article-title":"Geriatric assessment-identified deficits in older cancer patients with normal performance status","volume":"20","author":"Jolly","year":"2015","journal-title":"Oncologist"},{"issue":"8","key":"10.1016\/j.clml.2023.06.010_bib0045","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jgo.2022.08.019","article-title":"Functional status in older patients with cancer and a frailty risk profile: a multicenter observational study","volume":"13","author":"Meert","year":"2022","journal-title":"J Geriatr Oncol"},{"issue":"3","key":"10.1016\/j.clml.2023.06.010_bib0046","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1586\/17474086.2015.1024650","article-title":"Impact of comorbidities on the treatment of non-Hodgkin's lymphoma: a systematic review","volume":"8","author":"Terret","year":"2015","journal-title":"Expert Rev Hematol"},{"issue":"4","key":"10.1016\/j.clml.2023.06.010_bib0047","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bjh.12765","article-title":"Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study","volume":"165","author":"Wieringa","year":"2014","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.clml.2023.06.010_bib0048","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1007\/s00432-020-03279-7","article-title":"Impact of comorbidity and relative dose intensity on outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP","volume":"146","author":"Yamamoto","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"10.1016\/j.clml.2023.06.010_bib0049","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1111\/j.1532-5415.2012.04187.x","article-title":"Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: American Geriatrics Society expert panel on the care of older adults with multimorbidity","volume":"60","author":"Ickowicz","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.clml.2023.06.010_bib0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1634\/theoncologist.2017-0404","article-title":"Patient-reported comorbidity and survival in older adults with cancer","volume":"23","author":"Williams","year":"2018","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.clml.2023.06.010_bib0051","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/14737140.2022.2071262","article-title":"Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma","volume":"22","author":"Miura","year":"2022","journal-title":"Expert Rev Anticancer Ther"},{"issue":"22","key":"10.1016\/j.clml.2023.06.010_bib0052","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","article-title":"Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology","volume":"36","author":"Mohile","year":"2018","journal-title":"J Clin Oncol"},{"issue":"39","key":"10.1016\/j.clml.2023.06.010_bib0053","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1200\/EDBK_237641","article-title":"A practical guide to geriatric syndromes in older adults with cancer: a focus on falls, cognition, polypharmacy, and depression","author":"Magnuson","year":"2019","journal-title":"Am Soc Clin Oncol Educ B"},{"key":"10.1016\/j.clml.2023.06.010_bib0054","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9347804","article-title":"Prevalence of geriatric syndromes in elderly cancer patients receiving chemotherapy","volume":"2020","author":"Limpawattana","year":"2020","journal-title":"Curr Gerontol Geriatr Res"},{"issue":"2","key":"10.1016\/j.clml.2023.06.010_bib0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/onco.13610","article-title":"Challenges and opportunities in the management of diffuse large B-cell lymphoma in older patients","volume":"26","author":"Di","year":"2021","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.clml.2023.06.010_bib0056","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/bjh.17384","article-title":"The use of frailty assessments in treating older adults with aggressive lymphomas","volume":"194","author":"Cordoba","year":"2021","journal-title":"Br J Haematol"},{"issue":"22","key":"10.1016\/j.clml.2023.06.010_bib0057","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/bloodadvances.2021004777","article-title":"A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL","volume":"5","author":"Isaksen","year":"2021","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.clml.2023.06.010_bib0058","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/cncr.21422","article-title":"Developing a cancer-specific geriatric assessment: a feasibility study","volume":"104","author":"Hurria","year":"2005","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.clml.2023.06.010_bib0059","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/bjc.2015.120","article-title":"The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people","volume":"112","author":"Kalsi","year":"2015","journal-title":"Br J Cancer"},{"issue":"S1","key":"10.1016\/j.clml.2023.06.010_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5045\/br.2022.2021218","article-title":"Assessing frailty using comprehensive geriatric assessment in older patients with hematologic malignancy","volume":"57","author":"Choi","year":"2022","journal-title":"Blood Res"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023001982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023001982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:42:51Z","timestamp":1761871371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265023001982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2152265023001982"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2023.06.010","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment Individualization in Diffuse Large B-Cell Lymphoma: Is Frailty Enough for Old Adults? An Original Article","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2023.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}